Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Ralston

Showing results (141-150 of 275) with videos related to

Pageof 28
Sort By:
Disease Models & Mechanisms|August 30, 2018
Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62<sup>P394L</sup> mouse model of Paget's diseaseAnna Daroszewska, Lorraine Rose, Nadine Sarsam, et al.
The Journal of Biological Chemistry|December 18, 2007
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switchJed Long, Thomas R A Gallagher, James R Cavey, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 3, 2007
Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descentGavin Ja Lucas, Phillip L Riches, Lynne J Hocking, et al.
Calcified Tissue International|April 12, 2011
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiencyStuart H Ralston, Neil Binkley, Steven Boonen, et al.
BMC Health Services Research|June 10, 2006
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?Anne L Langston, Marie Johnston, Clare Robertson, et al.
Human Molecular Genetics|February 22, 2015
Targeted sequencing of the Paget's disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget's disease of boneMahéva Vallet, Dinesh C Soares, Sachin Wani, et al.
Calcified Tissue International|May 24, 2017
Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational StudyBarbara Hauser, Sizheng Zhao, Micaela R Visconti, et al.
Cell Metabolism|August 7, 2009
Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cellsAymen I Idris, Antonia Sophocleous, Euphemie Landao-Bassonga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Genetic and environmental determinants of peak bone mass in young men and womenFiona E A McGuigan, Liam Murray, Alison Gallagher, et al.
Human Molecular Genetics|April 26, 2011
A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in miceAnna Daroszewska, Robert J van 't Hof, Javier A Rojas, et al.
Pageof 28

Showing results (141-150 of 275) with videos related to

Sort By:
Pageof 28
Disease Models & Mechanisms|August 30, 2018
Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62<sup>P394L</sup> mouse model of Paget's diseaseAnna Daroszewska, Lorraine Rose, Nadine Sarsam, et al.
The Journal of Biological Chemistry|December 18, 2007
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switchJed Long, Thomas R A Gallagher, James R Cavey, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 3, 2007
Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descentGavin Ja Lucas, Phillip L Riches, Lynne J Hocking, et al.
Calcified Tissue International|April 12, 2011
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiencyStuart H Ralston, Neil Binkley, Steven Boonen, et al.
BMC Health Services Research|June 10, 2006
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?Anne L Langston, Marie Johnston, Clare Robertson, et al.
Human Molecular Genetics|February 22, 2015
Targeted sequencing of the Paget's disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget's disease of boneMahéva Vallet, Dinesh C Soares, Sachin Wani, et al.
Calcified Tissue International|May 24, 2017
Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational StudyBarbara Hauser, Sizheng Zhao, Micaela R Visconti, et al.
Cell Metabolism|August 7, 2009
Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cellsAymen I Idris, Antonia Sophocleous, Euphemie Landao-Bassonga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Genetic and environmental determinants of peak bone mass in young men and womenFiona E A McGuigan, Liam Murray, Alison Gallagher, et al.
Human Molecular Genetics|April 26, 2011
A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in miceAnna Daroszewska, Robert J van 't Hof, Javier A Rojas, et al.
Pageof 28